Institutional Clinical and Translational Science Award (U54)

The summary for the Institutional Clinical and Translational Science Award (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Institutional Clinical and Translational Science Award (U54): -The Clinical and Translational Science Award (CTSA) initiative assists institutions to create an integrated academic home for Clinical and Translational Science that has the resources to train and advance multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies that apply new knowledge and techniques to patient care. Clinical and Translational Science Awards (CTSAs) will attract basic, translational, and clinical investigators, community clinicians, clinical practices, networks, professional societies, and industry to develop new professional interactions, programs, and research projects. Through innovative advanced degree programs, CTSAs will foster a new discipline of Clinical and Translational Science that will be much broader and deeper than their separate components (definitions of Clinical and Translational Science are provided in Section I.1 of this document). -To succeed, CTSAs will need institutional support and the status of a major administrative entity within the applicant institution, and a Principal Investigator who has authority, perhaps shared with other high-level institutional officials, over requisite space, resources, faculty appointments, protected time, and promotion. NIH anticipates that diverse models will be proposed to fulfill these goals and welcomes innovative proposals that meet the needs of both the local institution and of the wider research community. -This RFA invites applications for institutional CTSAs that will enable applicants to innovate and to transform their own environment to develop and advance clinical and translational science as a distinct discipline. NIH Roadmap resources will give institutions flexibility to develop their existing resources and talent and to propose ways to increase the efficiency and speed of clinical and translational research. The academic home, which can be a center, department, or institute (C/D/I), is expected to include faculty who conduct original research, develop graduate and postgraduate training curricula and lead programs that integrate clinical and translational science across multiple departments, schools, research institutes and hospitals.